Genetic signature of adult gliomas and correlation with MRI features

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation WithMGMTPromoter Methylation Status

(2009) Alba A. Brandes et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

(2009) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status

(2009) Gurpreet S. Kapoor et al.   JOURNAL OF NEURO-ONCOLOGY

Novel Genomic Alterations and Mechanisms Associated With Tumor Progression in Oligodendroglioma and Mixed Oligoastrocytoma

(2009) David Blesa et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

(2009) Koichi Ichimura et al.   NEURO-ONCOLOGY

p53-mediated inhibition of angiogenesis in diffuse low-grade astrocytomas

(2009) Timo Gaiser et al.   NEUROCHEMISTRY INTERNATIONAL

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Analysis of the IDH1 codon 132 mutation in brain tumors

(2008) Jörg Balss et al.   ACTA NEUROPATHOLOGICA

Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study

(2008) M Wager et al.   BRITISH JOURNAL OF CANCER

Development of a Real-time RT-PCR Assay for Detecting EGFRvIII in Glioblastoma Samples

(2008) K. Yoshimoto et al.   CLINICAL CANCER RESEARCH

Novel Glioblastoma Markers with Diagnostic and Prognostic Value Identified through Transcriptome Analysis

(2008) S. P. Reddy et al.   CLINICAL CANCER RESEARCH

The Use of Magnetic Resonance Imaging to Noninvasively Detect Genetic Signatures in Oligodendroglioma

(2008) R. Brown et al.   CLINICAL CANCER RESEARCH

Frequent biallelic inactivation and transcriptional silencing of theDIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss

(2008) Markus J. Riemenschneider et al.   INTERNATIONAL JOURNAL OF CANCER

Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

(2008) Monika E. Hegi et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Diagnostic Testing in Malignant Gliomas: A Practical Update on Predictive Markers

(2008) Stephen Yip et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based Study

(2008) Izabela Zawlik et al.   NEUROEPIDEMIOLOGY

CXCR4 Expression is Elevated in Glioblastoma Multiforme and Correlates with an Increase in Intensity and Extent of Peritumoral T2-weighted Magnetic Resonance Imaging Signal Abnormalities

(2008) Charles B. Stevenson et al.   NEUROSURGERY

Identification of noninvasive imaging surrogates for brain tumor gene-expression modules

(2008) Maximilian Diehn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glioma Grading by Using Histogram Analysis of Blood Volume Heterogeneity from MR-derived Cerebral Blood Volume Maps

(2008) Kyrre E. Emblem et al.   RADIOLOGY

Relationship between Gene Expression and Enhancement in Glioblastoma Multiforme: Exploratory DNA Microarray Analysis

(2008) Whitney B. Pope et al.   RADIOLOGY

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

(2008) D. W. Parsons et al.   SCIENCE

Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma

(2008) John H. Sampson et al.   SEMINARS IN IMMUNOLOGY